Remove 2012 Remove Leads Remove Training
article thumbnail

MHRA Chief Executive to step down

European Pharmaceutical Review

Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pandemic, has been exceptional.” Her previous role in the agency was as Director of Vigilance and Risk Management of Medicines.

Safety 111
article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.

Medicine 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

pharmaphorum

A pharmacologist by training, Rawlins was the founding chairman of health technology assessment (HTA) agency NICE , leading the organisation from its inception in 1999 until 2013, and hired Sir Andrew Dillon to become the organisation’s founding chief executive.

article thumbnail

The Role of Certified Pharmaceutical Representatives in the Shifting Sales Landscape

Pharmaceutical Representative Training

Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. The DOJ’s investigation revealed that the company misled HCPs and patients about the risks associated with the opioid, leading to overprescription and abuse.

Sales 52
article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. in 2012 ( see more on LinkedIn ). Forging an AI-enabled path toward precision medicine. About Omnes Capital.

Medicine 105
article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

2012; 18 (6): 21-27. Dr Aurtenetxe has extensive experience in oncology research, both paediatric and medical, and has furthered her training with master’s degrees in basic and clinical oncology and clinical trials. Intern Med J. 2016; 46: 479–93. Can we identify patients at high risk of recurrent Clostridium difficile infection?

Safety 111
article thumbnail

Healthcare Systems Today And The Role Of Social Media Within It With Dr. Alejandro Badia

Evolve Your Success

Dr. Badia’s journey from his immigrant roots to becoming a leading medical practitioner in Miami is truly inspiring. Learn how a childhood experience with his grandmother’s rheumatoid arthritis ignited his passion for hand surgery, leading to his extensive training at N.Y.U. where he also trained in orthopedics.

Media 52